Amount Raised
$135 Million
Round Type
Post-IPO Equity
CambridgeBiotechnologyHealth CareGeneticsTherapeuticsInvestors
Description
On November 10, 2026, Prime Medicine, Inc. entered into an Underwriting Agreement for a public offering of 35,714,286 shares at $3.50 each. The company anticipates net proceeds of approximately $134.7 million to support its clinical programs and general corporate purposes. This funding will enhance the advancement of its key medical programs
Quick answer
Prime Medicine raised $135 Million in a Post-IPO Equity round, dated November 12, 2026. Investors: Goldman Sachs & Co. LLC, TD Securities (USA) LLC and Jefferies LLC. Prime Medicine is based in Cambridge, Massachusetts, United States.
- How much did Prime Medicine raise?
- Prime Medicine raised $135 Million in a Post-IPO Equity round on November 12, 2026.
- Who invested in Prime Medicine?
- Goldman Sachs & Co. LLC, TD Securities (USA) LLC and Jefferies LLC are named as investors in this round.
- What does Prime Medicine do?
- Prime Medicine is a leading biotechnology company dedicated to creating and delivering the next generation of gene editing therapies to patients.
- Where is Prime Medicine based and how big is it?
- Prime Medicine is based in Cambridge, Massachusetts, United States. Fundz records about 205 employees.
- Who are the decision-makers at Prime Medicine?
- Fundz holds 2 contacts at Prime Medicine, including the Advisor. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Genetics and Therapeutics around the same time
Companies in the same sectors as Prime Medicine that raised within 45 days of this round, from Fundz verified event records.
- VolitionRx raised $2.4M (Convertible Note) on October 27, 2026.
- Estuary Biotherapeutics raised $93M (Series A) on October 16, 2026.
- seragy holding GmbH raised $13M on October 14, 2026.
- Aptadir Therapeutics raised $45M (Seed) on September 29, 2026.
- Orakl Oncology raised $34M (Series A) on November 12, 2026.
- VectorY raised $83M on November 11, 2026.
Who to call at Prime Medicine, and when
A new round usually means Prime Medicine is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Prime Medicine raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Prime Medicine, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Prime Medicine. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Prime Medicine raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Prime Medicine raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.